Treace Medical Concepts, Inc. (TMCI) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts TMCI Hot Sheet
Join SI Premium – FREE
Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q1 EPS of ($0.25), in-line with the analyst estimate of ($0.25). Revenue for the quarter came in at $52.6 million versus the consensus estimate of $52.7 million.
For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westport Fuel Systems (WPRT) Misses Q2 EPS by 64c
- Snail, Inc. (SNAL) Reports Q3 Loss of $0.36
- Immunome, Inc. (IMNM) Reports Q2 Loss of $0.65
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
